HILE: The transaction price for the major asset purchase has been adjusted to 536 million yuan

Zhitong
2025.09.15 09:13

HILE announced that the company has signed a supplementary agreement with Meilun Management Co., Ltd. to adjust the transaction price for a major asset purchase. According to the assessment by Beijing Zhuoxin Dahua Asset Appraisal Co., Ltd., the total equity value of Ruisheng Bio's shareholders is 974 million yuan, down from the original 1.7 billion yuan. Therefore, the transaction price has been adjusted from 935 million yuan to 536 million yuan, and Meilun will return the price difference of 399 million yuan. This adjustment does not affect the company's holding of 55% equity in Ruisheng Bio and helps to reduce investment risks and the risk of failing to meet performance commitments. The adjusted commitments for non-recurring net profit for 2025 and 2026 are 50 million yuan and 58 million yuan, respectively